UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
(State of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(
(Registrant's telephone number, including area code)
Not
Applicable
(Former name, former address and former fiscal year, if changed since last report date)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||
Title of each class | Ticker symbol(s) | Name of each exchange on which registered |
The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 7.01 Regulation FD Disclosure
On March 22, 2022, Precipio, Inc (the "Company") announced that management will host a Q4-2021 and year-end Shareholder Update Call on Monday April 4th at 5:00 PM EST. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 | Precipio Inc Press Release |
104 | Cover Page Interactive Data File (cover page XBRL tags are embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PRECIPIO, INC. | ||
By: | s/ Ilan Danieli | |
Name: | Ilan Danieli | |
Title: | Chief Executive Officer |
Date: March 22, 2022
Exhibit 99.1
Precipio Announces
2021 Fourth Quarter and Year-End
Shareholder Update Call
Conference Call to be held on Monday, April 4th, 2022 at 5:00 PM EST
NEW HAVEN, CT, Globenewswire – (March 22nd, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2021 and year end shareholder update call on Monday, April 4th at 5:00 PM ET. The call will include updates on the Company’s current core businesses.
The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call at https://dpregister.com/sreg/10164970/f20eec96a8. For those that pre-register for the shareholder call, the host service will send a calendar invitation and a direct dial-in number for the call to your email used during registration, which will allow for the registrant to bypass the operator.
Listeners interested in submitting questions in advance should email their questions to investors@precipiodx.com and management will do its best to address those questions during the call.
A replay of the call will be available approximately 24 hours after the call and may be accessed via the investors page located on Precipio's website or at http://www.precipiodx.com/investors.html.
About Precipio
Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit www.precipiodx.com.
Please follow us on Twitter @PrecipioDx and on Facebook.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “will,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, or could affect the company’s ability to achieve its strategic goals, include the uncertainties relating to the impact of COVID-19 on the company’s business, operations and employees and the other factors that are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis” in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as updated from time to time in the company’s Securities and Exchange Commission filings.
The company’s forward-looking statements in this press release are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
Inquiries:
investors@precipiodx.com
+1-203-787-7888 Ext. 523
Cover |
Mar. 22, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 22, 2022 |
Entity File Number | 001-36439 |
Entity Registrant Name | PRECIPIO, INC. |
Entity Central Index Key | 0001043961 |
Entity Tax Identification Number | 91-1789357 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 4 Science Park |
Entity Address, City or Town | New Haven |
Entity Address, State or Province | CT |
Entity Address, Postal Zip Code | 06511 |
City Area Code | 203 |
Local Phone Number | 787-7888 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.01 par value per share |
Trading Symbol | PRPO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
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end
FU#IY*X@& ]
MK_S(^D62_TC^],-^FZ)GPK.$T;/1].CC"!$:L3BAF[/1U^7X?#E?+$8HRS&-
M< TRAT'&V<(;D8>#.$F9H4K@U9(*(V*9>NSUWGDR^OA0T"#A[/(&B
MT:8(OE+./PBY$F-*M!0T*=*!T"R!MP@T$HASDC5RT<+P1?+,DE+Y E3E^2YX
M3*'8$> ]?=][\7>
MO"#]"FOP&Q40T7M%8KXR)([=0HWB"B\2HCSD0_90]J@;/_U"$>C?F055^_=6
MN4,CF]^%%E34EX)& B6MA8K&N][NO7T@>+D]L(,R1TQ@JX3A[>/*IIS%0RY)
M\+[]P S*%;K9"%AOB:B$>5+4V\N5 D41-_W&7DRMU-YX-<^UBIM. 7#H8DD^OVSM;N<+!WT4'>
M!8-\!:=<;=;K+=WSTAT#U,$(X+^Z#C:<5L$X%M4:NLHFYVQZEP'/E,EE2X77
M##!?"O&MC)BNPO_.J48'=WVJV>P5K HG8.G:G73G.PR/)WSU&A[R76=(+6;?
MR7?"/WI,;/'=:_C44)>6SRN[I-)*YCU#G1+;F6KL.-$' !X0*6,ZI,M'0'+%
MQJ1MC*B^YWVQ!PI8O"^@KO*GH)_*;5.CTP.B&SH3C7QR@)AE%BX&\8FK*M/%
MTL"/0'CECH"7XJ%^XK31GYQ:Q@BQDLQDD[+L&/._$T2'48,HQ@]BT9 HS^%P
ME(Z(^!&IGG,]3H!#/N@9X'JH+F 2UB>"HD19M,>JD(X8 C4"/\DL"-[,]BC0
M(1_8(M*":D2$SX.A\+6F91K)8"&E)K::\)L=#R'@-&];Z@93N:)3T+*H5D2!X$O?I%$[
MNSKWC P+ R3O
M;H_JD+,^5%/!(]]-\ ZO6+6$==MM<680!T02[ QBJ
ME!_4!R1CT T-"9S9&XH[\P_.;"@XLZ#!F;T'G-4+"PB
+-89N.[+R?._LZQHW>VN)?V[Z-Z1_U1B-N(UG
MI@0A3KPI^'WT;Z3:J4Z*U$>F9DR91:* (E=&:FDL<\RD12PK;R" BN46#/?]
M-SN6E[846=H55;68;?N_+KC.I/AE_:WTF.E]JTWV/YEF;&=FP"5P4=1L#)Z?#4_QR>C?8'0QNCP[&G3\)]YVRM>#XU>G[]GUZ/WEV>\[$Y79
M ];KYI:-9"H,>RGF[(U*>=;R#UKL6F@YV<%$3+VJYJ5<3V5VP+J'S(I;&_!$
M3O%3RVEL=XX&QT=GM[$<2\OV]]N]0><8BEQ]2L3.T8-L;/+#S2&KHD.16:$/
MF9\66)6[U
%UQ#".-9Q-X+KH.S
M+!H